The Conscience Board of Directors welcomes its two newest Board appointments: Owen Roberts and John Wilbanks.
Owen and John bring a wealth of experience in the development of solutions and innovation in health and drug development. Owen has helped to grow and lead new ventures and established organizations in pharma and biotech. John has over a decade of experience bringing together open science, technology, and related policy work, which he successfully translated to impactful products and services with companies like Sage Bionetworks and Biogen. We’re delighted to have their skills and experiences at the Board as we grow Conscience and set our future goals.
John and Owen were both formally elected to our Board of Directors in late 2023. We look forward to their contributions to Conscience’s mission.
Their full bios can be found here.
